Artemis Medicare schedules Q2 and H1 FY27 earnings call

Board & Shareholder Meetings View source PDF Explain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹288.00

prior close

₹300.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+2.3% vs market

Hospital peers, median of 27sector+1.4%+2.6% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.0

15m

-0.2

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0+1.7+2.3+1.4+2.6

Next day

+3.8pendingpending+2.2+1.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Artemis Medicare Services will discuss its Q2 and H1 FY27 operational and financial performance with investors and analysts on November 2, 2026 at 11:00 AM IST. Anand Rathi Research will host the call, with the Managing Director and Chief Financial Officer participating.

Likely market impact

The call may help investors assess the company's financial and operating performance, but this filing contains no new performance figures.